associated with the two-dimensional atomic crystal structure. [1] To best utilize this material for practical applications, it is crucial to prevent the spontaneous aggregation between individual graphene sheets while composite materials are formed. Numerous efforts have been made to stabilize functionalized graphene sheets on molecular [2, 3] or polymeric species. [4, 5] Biomolecules such as DNA [6] and proteins [7] have also been grafted onto graphene planes and used for biosensors, [8] controlled drug-delivery [9] as well as cancer imaging. [10] Besides biomedical applications, graphene sheets can also be hybridized with biomolecules into energy storage devices to increase the conductivity of the active materials that are often insulators. In previous work, ultrasonication [11] or chemical reduction, [12] followed by heat treatment, [13] [14] [15] have been adopted to achieve composites between graphene and various materials (LiFePO 4 [11] and SnO 2 [16] ). However, due to the nonspecific nature of the interactions between the graphene templates and active materials, it is expected that only random and inhomogeneous contacts are created, leaving the segregation on nano-or even sub-micron levels. Ideally, the performance of these active materials, such as the accessible capacity and the rate capability, can be maximized only if atomic level contacts can be realized between the conductive phase (graphene) and the active phase.
In order to expand the range of graphene based hybrid materials, methods to prevent aggregation around the limit of colloidal stability need to be developed. The stability of aqueous colloidal dispersion of functionalized graphene is usually maintained at high pH and low ionic strength due to the charges on the functionalized surface. [17] Substrate specificity of ligands in biomolecules can improve the colloidal stability of graphene and strengthen the interaction between graphene and functional materials, thereby providing a genetically tunable hybrid building block and a desired conducting frame. The M13 bacteriophage has been demonstrated as a genetically engineerable biological toolkit to develop nanostructured hybrid materials to enhance the performance of energy storage and conversion devices. [18, 19] Here, we show that the non-covalent binding between the engineered M13 virus and graphene increased the dispersion stability of graphene sheets at a pH as low as 3 and an increased ionic strength environment. In addition, using this biological engineering approach, we were able to take a DNA sequence that coded for peptides that could bind graphene and modified this sequence to further broaden the stability window of the aqueous colloid of graphene sheets. With the improved stability of graphene in aqueous media, inorganic nanoparticles nucleated on the M13 virus were able to intimately interface with graphene sheets and fully utilized the excellent electronic conductivity of graphene, although the incorporation of graphene might lower the packing density. As a result, we achieved an efficient conducting matrix throughout the hybrid material with the genetically engineered M13 virus, which simultaneously stabilizes graphene sheets and mineralizes the active nanoparticles. We also demonstrated that the electrochemical utilization of the originally insulating active materials could be maximized in the composite network consisting of active nanoparticles and conductive graphene sheets.
We utilized an M13 virus to synthesize a graphene/virus complex to function as a building block for a conducting framework. The M13 virus is a filamentous bacteriophage, with a length of ~880 nm and a diameter of ~6.5 nm. [20] The single-stranded DNA encapsulated inside the coat proteins can be modified to express specific peptide sequences on the surface of the virus to enhance the interaction with materials of interest. [21, 22] To fabricate a virusmediated graphene framework with inorganic nanoparticles, two factors must be addressed; the colloidal stability of graphene and the interface between the active materials and the graphene. In designing an M13 virus, the major coat protein (pVIII) was chosen as a major interacting motif to maximize the attraction between the graphene and the virus, so that every particle templated on the virus was forced to contact the graphene (Figure 1a) . First, the graphene-binding virus, with an 8-mer peptide insert, DVYESALP, fused to the aminoterminus of the pVIII major coat protein (this virus is called p8cs#3), was identified through a bio-panning method using a pVIII library previously reported by this group. [19] The aromatic residue, tyrosine (Y), of the selected sequence is expected to interact with graphene, as well as single-walled carbon nanotubes (SWNTs), through π-π interaction. In addition to the aromatic residue, the hydrophobicity plot of the sequence, calculated based on the Hopp-Woods scale with the averaging group size 5, [23] shows a hydrophobic moiety between two hydrophilic regions (Figure 1b inset) suggesting that the virus can bind graphene by hydrophobic-hydrophobic interaction. Second, to facilitate the nucleation of nanoparticles, we introduced two additional carboxyl groups on each pVIII protein of p8cs#3 virus, in which the thirteenth amino acid, lysine (K), and the seventeenth amino acid, asparagine (N), were changed to the glutamic acid (E), using site-directed mutagenesis (Figure 1b top) (this site-mutated virus is called EFE). Since the thirteenth and seventeenth amino acids of an M13 virus are known to be exposed on the surface and accessible to ligands, [24] these carboxyl groups of glutamic acid can chelate metal ions and catalyze the mineralization. The zeta potential of EFE was measured and compared with that of the control virus, p8cs#3, to confirm the effect of the site-directed mutation on the surface charge of the virus (Figure 1b bottom) . It was observed that the isoelectric point of the virus shifted to a lower pH by the addition of two glutamic acids on the pVIII protein. The increased negative charges associated with the carboxyl groups have additional advantages in enhancing the colloidal stability of the graphene/virus complex. Finally, the pIII minor coat protein was also engineered to increase the binding affinity between the virus and the graphene (see the method in Supporting Information). We designate this virus clone as FC#2 and use it for further research on stabilizing graphene, nucleating functional materials and improving the performance of lithium ion batteries. The stability of the graphene/virus complex was tested by adding bismuth nitrate (the precursor for the material of interest for lithium ion batteries) at pH 3. The stability of graphene dispersion by the virus was maintained after 24 hours of incubation with bismuth nitrate as shown in Figure 1c . This is in contrast to the control sample under the same salt concentration and pH without the virus, where the graphene aggregated. We also observed the graphene/virus (FC#2) complex by atomic force microscopy (AFM) (Figure 1d ). An area with the relatively lower coverage of the virus on the graphene compared to the approximate calculation (see the Supporting Information for the calculation) was selected to clearly visualize the interaction of the virus and the graphene. The thickness of the graphene in the solution was around 0.8 nm as indicated in Figure 1d inset.
Leveraging the enhanced colloidal stability of the genetically programmed graphene/virus complex, we assembled bismuth oxyfluoride on the graphene/virus template. Bismuth oxyfluoride is a conversion reaction cathode material with an open circuit voltage of 2.8 V vs Li/Li + , a high theoretical specific capacity of 210 mAh g −1 (for BiO 0.5 F 2 , from LiF formation) and an attractive volumetric energy density of 5056 Wh l −1 (for BiO 0.5 F 2 , higher than LiCoO 2 with 2845 Wh l −1 ), [25] which can be synthesized in aqueous solution under low pH conditions. Among the candidates of cathode materials for next generation lithium ion batteries, bismuth oxyfluoride was chosen as a model material, since we found the synthetic condition for this material under a weak acidic environment, suitable for demonstrating the improved colloidal stability of the graphene. Since the M13 virus helped maintain the colloidal stability of the graphene during the nucleation of inorganic nanoparticles under low pH, it is now possible to form hybrid nanostructures of the graphene/BiO 0.5 F 2 . We first developed an aqueous solution-based approach to synthesize bismuth oxyfluoride nanoparticles on the virus under a weakly acidic condition at room temperature, using LiF as a milder precursor than hydrofluoric acid [26] and ammonium fluoride. [27] Nanoparticles, thus synthesized, have a diameter of around 40 nm (Figure 2a,b) . The virus-mediated synthesis increased the reaction yield (from 17% without virus to 63% with virus, both without graphene) and decreased the particle size of the material compared with the previous report. [26] To fabricate the nanocomposites of the water-soluble graphene (Figure 2c ) and bismuth oxyfluoride, the graphene was first complexed and stabilized by the FC#2 virus, and then bismuth oxyfluoride was grown on the virus/graphene complex. In order to visualize the hybrid structure with graphene, we used a lowered concentration of the precursor to show that more bismuth oxyfluoride was nucleated along the virus than on the surface of graphene (Figure 2d ). The chemically modified graphene (see Supporting Information for graphene synthesis) possesses functional groups, which also act as nucleation sites, but the graphene-assisted nucleation is not as efficient as the virus-assisted nucleation. Two control hybrid materials with the graphene were synthesized without using the virus or with a wild type virus (M13KE, denoted in our work as a wild type virus). In addition to the reduced colloidal stability as shown in Figure 1c , the yield of bismuth oxyfluoride of the reaction without the virus (42%) was much lower than the yield of the reaction aided by the FC#2 (68%). For the nanocomposites made with the wild type virus, the graphene was initially stabilized by non-specific interaction, but the graphene aggregation and the separation between the graphene and active materials eventually prevailed as the nucleation proceeded (Figure 2e) . Furthermore, the positive surface charge from the wild type virus under weakly acidic conditions (pH 3) did not facilitate the nucleation of bismuth oxyfluoride and the yield was similar to the reaction without the virus.
The crystal structure of the virus-templated bismuth oxyfluoride was confirmed as cubic (Fm-3m) by high-resolution transmission electron microscopy (HRTEM) (Figure 2b ) and Xray diffraction (XRD) (Figure 2f) , with a lattice parameter of 5.8160(1) Å. From X-ray photoelectron spectroscopy (XPS) elemental analysis, the bismuth-to-fluorine ratio was determined to be 1:2.02 (Table S2) , giving a chemical formula of BiO 0.49 F 2.02 . The galvanostatic measurement (at a current density of 6 mA g −1 ) further confirmed the composition of fluorine and oxygen based on the fact that oxygen and fluorine in bismuth oxyfluoride react with the lithium at different potentials of 1.8 V and 2.6 V (vs Li/Li + ). [25] In Figure S2B , the ratio of discharge capacity in the plateau regions around 2.7 V and 1.9 V was calculated to be 1.95:1.05. Because the ethyl methyl carbonate (EMC) electrolyte is believed to be inert to Bi nanocrystals, [28] the solid electrolyte interphase formation does not occur under 2 V, therefore does not contribute to the capacity. Since each fluorine atom reacts with one lithium atom and each oxygen atom reacts with two lithium atoms, the galvanostatic measurement gave a chemical formula of BiO 0.525 F 1.95 , in fairly good agreement with the XPS analysis result. Therefore we concluded with a reasonable approximation that the chemical formula of the synthesized bismuth oxyfluoride was close to BiO 0.5 F 2 .
The advantage of incorporating well-dispersed graphene into lithium ion battery cathodes was demonstrated by making electrodes with the graphene/bismuth oxyfluoride nanocomposites assembled with a biologically engineered virus. With a small amount (2.4 wt%) of graphene incorporated into the bismuth oxyfluoride, the specific capacity of the virus-templated bismuth oxyfluoride was increased from 124 mAh g −1 to 174 mAh g −1 at a current density of 30 mA g −1 (C/7) (Figure 3a and Figure 3b ). The second cycle capacity (206 mAh g −1 , at C/7) of the virus templated bismuth oxyfluoride with 2.4 wt% of graphene in Figure S4 corresponds to 98% of theoretical capacity, which is the highest reported for this material to date. Moreover, the rate performance has also been improved, showing a specific capacity of 131 mAh g −1 (corresponding to 711 W kg −1 , with an energy density of 316 Wh kg −1 , 2718 Wh l −1 ) at a current density of 300 mA g −1 (1.4 C) compared to 67 mAh g −1 for the virus-templated bismuth oxyfluoride without graphene. These results represent a significant improvement in the electrochemical performance of bismuth oxyfluoride compared to the previous report, as indicated by the increased active mass loading in the electrode (from 50 wt% to 70 wt%) and the improved specific capacity at a 20 times higher current density. In addition, the presence of the graphene also significantly decreased the voltage hysteresis between the charge and the discharge profiles ( Figure S4 ), which became more pronounced at a higher discharging rate (Figure 3a) . This reduction in the electrode overpotential stems from the excellent electric wiring achieved at the atomic level by graphene sheets, which connects active nanoparticles with the cell current collector through a homogeneously distributed percolating conductive network.
To study the beneficial effect of specific interaction between the genetically engineered virus and the graphene in the formation of a conducting framework, control experiments have been done with graphene/bismuth oxyfluoride nanocomposites synthesized in the absence of the virus or in the presence of the wild type virus. The bismuth oxyfluoride synthesized in the control experiments had the same chemical and crystallographic properties as that formed with FC#2 ( Figure S5 shows XRD patterns for each composite). As shown in Figure 3a , c and d, the specific capacity (174 mAh g −1 at C/7) of nanocomposites using FC#2 was higher than that of nanocomposites using the wild type virus (145 mAh g −1 at C/7) and without the virus (102 mAh g −1 at C/7). Moreover, the superior electrochemical performance of the nanocomposites using FC#2 was more apparent at a high rate of 600 mA g −1 (110 mAh g −1 for FC#2, 67 mAh g −1 for the wild type virus and 64 mAh g −1 without the virus), indicating accelerated electrode kinetics for the cell reactions in those nanocomposites benefiting from the specific interaction between the graphene and FC#2 virus. The poor electrochemical activities of the nanocomposites in the presence of the wild type virus and in the absence of the virus are caused by the agglomeration of graphene during the active material synthesis. Based on these observations, we conclude that the increased interaction of graphene with the active material particles aided by the genetically engineered virus results in an efficient conducting network. This was made possible by maintaining the colloidal stability of complex during the synthesis. Moreover, we achieved both higher capacity utilization of the active materials and a much reduced kinetic barrier between charge and discharge reactions, as compared with the previous report. [25] The superior formation of a percolating network with two-dimensional conducting sheets enabled by the genetically engineered virus has also been demonstrated by comparing the effects of graphene and SWNTs on the electrochemical performance of bismuth oxyfluoride. The SWNTs were evenly dispersed inside the electrode by the virus complexation method [19] and bismuth oxyfluoride was synthesized on this template. When the same amount of graphene and SWNTs (0.5 wt%) were incorporated into the nanocomposites, the specific capacities of 128 mAh g −1 for the SWNTs/bismuth oxyfluoride nanocomposites and 181 mAh g −1 for the graphene/bismuth oxyfluoride nanocomposites were obtained respectively, at a current density of 30 mA g −1 (Figure 3e ). The graphene improves the kinetics of the conversion reaction more effectively than SWNTs. Although the SWNTs are known to be advantageous for constructing a percolating network because of their high aspect ratio, [29] when a small quantity of carbon is used, the interconnectivity between the one-dimensional SWNTs could be limited compared to the two-dimensional graphene. In the bismuth oxyfluoride system, the graphene appears to be more effective in facilitating the electrochemical reaction.
In summary, using a genetically engineered M13 virus, we broadened the stability window of graphene in aqueous media, which enabled an environment-friendly approach to establish a graphene/virus nanotemplate. By designing the M13 virus for simultaneously stabilizing the graphene and nucleating bismuth oxyfluoride, we fabricated the graphene/bismuth oxyfluoride nanocomposites in which both phases were intimately interwoven. The graphene/virus complex formed a homogeneously distributed conducting framework and the kinetics of electron transfer inside the battery electrodes was improved, demonstrating the increased specific capacity of bismuth oxyfluoride at a high current density (131 mAh g −1 at 300 mA g −1 ) and the reduced overpotentials for both charging and discharging cell reactions. This study demonstrates the importance of well-dispersed graphene in aqueous media for synthesizing composite materials and this general method could be extended to other materials for applications including biosensors, supercapacitors, catalysts and energy conversion applications.
Experimental
Synthesis of bismuth oxyfluoride powders, bismuth oxyfluoride and graphene nanocomposites for FC#2 virus, wild type virus and without virus FC#2 viruses (2×10 13 ) were incubated with the graphene solution (64 ml, 2.3 µg ml −1 ). Bi(NO 3 ) 3 ·5H 2 O (0.8ml, 200 mM, dissolved in 10% HNO 3 ) was added to this mixture to make the final solution (400 ml, 0.4 mM). LiF solution (171 ml, 50 mM) was added and stirred at room temperature for 3 hours. Graphene solution (40 ml, 50 µg ml −1 ) was further added into the nanocomposites. The final products were filtered, washed and dried under vacuum at 50°C overnight. With the same method, wild type viruses were used for bismuth oxyfluoride/graphene nanocomposites and virus addition and incubation steps were excluded for composites without virus.
Synthesis of bismuth oxyfluoride and SWNTs nanocomposites
The SWNT/FC#2 complexes were constructed by dialyzing the mixture of FC#2 (2×10 13 ) and SWNTs (0.094 mg in 2 wt% sodium cholate aqueous solution) against D.I. water with gradual increase of salt (KCl) concentration of media from 10 mM to 80 mM, while maintaining pH 9 using NaOH for two days. Bismuth oxyfluoride was synthesized by adding Bi(NO 3 ) 3 ·5H 2 O (0.8 ml, 200 mM, dissolved in 10% HNO 3 ) to complex solution giving final volume to 400 ml. After an hour, LiF (171 ml, 50 mM) was added and rested for 2 hours. The final products were washed and dried under vacuum at 50°C overnight.
Electrochemical tests
Active materials were mixed mechanically with Super P (TIMCAL, SUPER P ® Li) for 20 minutes and polytetrafluoroethylene (PTFE) was added. (Active materials : virus : graphene : Super P : PTFE (mass ratio) = 68.8 : 8.8 : 2.4 : 15 : 5). Mixed powders were rolled out and punched in 4.08 mg cm −2 and dried under vacuum at 120°C overnight. Inside the Ar-filled glove box, the electrodes were assembled into coin cells with Li metal foils as the counter electrodes and 1 M LiPF 6 in EMC was used as the electrolyte. Three layers of microporous polymer separator (Celgard 2325) were used. Assembled coin cells were tested with a Solatron Analytical 1470E potentiostat at room temperature.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. The power performance of the graphene/bismuth oxyfluoride nanocomposites with the genetically engineered M13 virus. a-d) The first discharge of bismuth oxyfluoride at different current densities; a) the bismuth oxyfluoride/graphene nanocomposites with FC#2, b) the bismuth oxyfluoride templated on FC#2 without graphene, c) the bismuth oxyfluoride/graphene composites in the absence of virus, d) the bismuth oxyfluoride/ graphene composites in the presence of the wild type virus. e) Comparison between the graphene and SWNTs: The first discharge of the bismuth oxyfluoride/graphene composites and the bismuth oxyfluoride/SWNTs composites formed with FC#2 viruses having the same mass percentage of carbon (0.5 wt% of electrodes) at a 30 mA g −1 of current density.
